Michael A Metzger - Net Worth and Insider Trading
Michael A Metzger Net Worth
The estimated net worth of Michael A Metzger is at least $363,246 dollars as of 2024-04-25. Michael A Metzger is the CEO of Syndax Pharmaceuticals Inc and owns about 17,659 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $363,246. Michael A Metzger is also the Director of CTI BioPharma Corp and owns about 0 shares of CTI BioPharma Corp (CTIC) stock worth over $0. Details can be seen in Michael A Metzger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael A Metzger has not made any transactions after 2023-02-06 and currently still holds the listed stock(s).
Transaction Summary of Michael A Metzger
Michael A Metzger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael A Metzger owns 4 companies in total, including CTI BioPharma Corp (CTIC) , Syndax Pharmaceuticals Inc (SNDX) , and Regado Biosciences Inc (RGDO) among others .
Click here to see the complete history of Michael A Metzger’s form 4 insider trades.
Insider Ownership Summary of Michael A Metzger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2022-11-08 | director |
| SNDX | Syndax Pharmaceuticals Inc | 2023-02-06 | President and COO |
| RGDO | Regado Biosciences Inc | 2014-12-03 | director & President & CEO |
| RGDXQ | Response Genetics Inc | 2012-07-30 | director |
Michael A Metzger Latest Holdings Summary
Michael A Metzger currently owns a total of 2 stocks. Among these stocks, Michael A Metzger owns 17,659 shares of Syndax Pharmaceuticals Inc (SNDX) as of February 6, 2023, with a value of $363,246 and a weighting of 100%. Michael A Metzger also owns 0 shares of CTI BioPharma Corp (CTIC) as of November 8, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Michael A Metzger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2023-02-06 | 17,659 | 20.57 | 363,246 |
| CTIC | CTI BioPharma Corp | 2022-11-08 | 0 | 9.09 | 0 |
Holding Weightings of Michael A Metzger
Michael A Metzger Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael A Metzger has made a total of 14 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 5,959 shares on February 6, 2023, which brought Michael A Metzger around $164,707.
According to the SEC Form 4 filings, Michael A Metzger has made a total of 3 transactions in CTI BioPharma Corp (CTIC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CTI BioPharma Corp is the sale of 91,500 shares on November 8, 2022, which brought Michael A Metzger around $510,570.
Insider Trading History of Michael A Metzger
- 1
Michael A Metzger Trading Performance
Michael A Metzger Ownership Network
Ownership Network List of Michael A Metzger
Ownership Network Relation of Michael A Metzger
Michael A Metzger Owned Company Details
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Michael A Metzger is the director of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
Over the past 18 months, Michael A Metzger made 1 insider transaction in CTI BioPharma Corp (CTIC) with a net sale of 91,500. Other recent insider transactions involving CTI BioPharma Corp (CTIC) include a net sale of 327,617 shares made by Adam R Craig , a net sale of 100,000 shares made by James K Fong , and a net sale of 54,042 shares made by David Kirske .
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 573,159 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 573,159 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
Michael A Metzger Mailing Address
Above is the net worth, insider trading, and ownership report for Michael A Metzger. You might contact Michael A Metzger via mailing address: C/o Syndax Pharmaceuticals, Inc., 400 Totten Pond Road,, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
